Banca IFIS Valuation

Is 0NBX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0NBX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0NBX (€20.22) is trading above our estimate of fair value (€19.09)

Significantly Below Fair Value: 0NBX is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0NBX?

Key metric: As 0NBX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0NBX. This is calculated by dividing 0NBX's market cap by their current earnings.
What is 0NBX's PE Ratio?
PE Ratio6.5x
Earnings€161.94m
Market Cap€1.05b

Price to Earnings Ratio vs Peers

How does 0NBX's PE Ratio compare to its peers?

The above table shows the PE ratio for 0NBX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.2x
EQLS Equals Group
27.1x32.0%UK£220.7m
DUKE Duke Capital
10x18.0%UK£115.6m
BUR Burford Capital
11.2x24.6%UK£2.3b
LIT Litigation Capital Management
20.5x18.2%UK£134.3m
0NBX Banca IFIS
6.5x2.4%€1.0b

Price-To-Earnings vs Peers: 0NBX is good value based on its Price-To-Earnings Ratio (6.5x) compared to the peer average (17.2x).


Price to Earnings Ratio vs Industry

How does 0NBX's PE Ratio compare vs other companies in the GB Diversified Financial Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
NBS Nationwide Building Society
0.9xn/aUS$1.51b
No more companies available in this PE range
0NBX 6.5xIndustry Avg. 13.3xNo. of Companies3PE01020304050+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0NBX is good value based on its Price-To-Earnings Ratio (6.5x) compared to the UK Diversified Financial industry average (13.4x).


Price to Earnings Ratio vs Fair Ratio

What is 0NBX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0NBX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio6.5x
Fair PE Ratio13.5x

Price-To-Earnings vs Fair Ratio: 0NBX is good value based on its Price-To-Earnings Ratio (6.5x) compared to the estimated Fair Price-To-Earnings Ratio (13.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0NBX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€20.22
€23.87
+18.1%
3.2%€25.00€22.90n/a6
Nov ’25€22.11
€23.70
+7.2%
3.0%€25.00€22.90n/a6
Oct ’25€21.41
€23.50
+9.8%
4.3%€25.00€21.70n/a6
Sep ’25€21.16
€23.50
+11.1%
4.3%€25.00€21.70n/a6
Aug ’25€21.40
€23.17
+8.3%
3.7%€24.10€21.70n/a6
Jul ’25€20.36
€22.52
+10.6%
6.5%€24.10€19.80n/a6
Jun ’25€20.02
€22.52
+12.5%
6.5%€24.10€19.80n/a6
May ’25€21.00
€21.30
+1.4%
9.9%€24.10€18.70n/a6
Apr ’25€18.15
€20.10
+10.7%
7.8%€21.50€17.00n/a6
Mar ’25€17.13
€20.10
+17.4%
7.8%€21.50€17.00n/a6
Feb ’25€16.15
€19.97
+23.6%
7.6%€21.50€17.00n/a6
Jan ’25€15.79
€20.05
+27.0%
6.7%€21.50€17.50n/a6
Dec ’24€15.86
€20.05
+26.4%
6.7%€21.50€17.50n/a6
Nov ’24€16.45
€20.22
+22.9%
6.7%€21.50€17.50€22.116
Oct ’24€16.41
€20.22
+23.2%
6.7%€21.50€17.50€21.416
Sep ’24€16.13
€20.22
+25.3%
6.7%€21.50€17.50€21.166
Aug ’24€15.75
€19.50
+23.8%
7.0%€21.00€16.80€21.406
Jul ’24€14.69
€19.50
+32.7%
7.0%€21.00€16.80€20.366
Jun ’24€14.22
€19.50
+37.1%
7.0%€21.00€16.80€20.026
May ’24€15.18
€19.40
+27.8%
7.4%€21.00€16.80€21.006
Apr ’24€14.02
€19.40
+38.4%
7.4%€21.00€16.80€18.156
Mar ’24€15.55
€19.93
+28.2%
7.6%€21.50€16.80€17.136
Feb ’24€15.31
€18.28
+19.4%
5.5%€19.50€16.50€16.156
Jan ’24€13.26
€18.28
+37.9%
5.5%€19.50€16.50€15.796
Dec ’23€13.02
€18.28
+40.4%
5.5%€19.50€16.50€15.866
Nov ’23€12.11
€19.52
+61.2%
13.1%€24.00€16.50€16.455

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies